Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

A novel homozygous mutation in GAD1 gene described in a schizophrenic patient impairs activity and dimerization of GAD67 enzyme.

Magri C, Giacopuzzi E, La Via L, Bonini D, Ravasio V, Elhussiny MEA, Orizio F, Gangemi F, Valsecchi P, Bresciani R, Barbon A, Vita A, Gennarelli M.

Sci Rep. 2018 Oct 19;8(1):15470. doi: 10.1038/s41598-018-33924-8.

2.

Real-world clinical applicability of pathogenicity predictors assessed on SERPINA1 mutations in alpha-1-antitrypsin deficiency.

Giacopuzzi E, Laffranchi M, Berardelli R, Ravasio V, Ferrarotti I, Gooptu B, Borsani G, Fra A.

Hum Mutat. 2018 Sep;39(9):1203-1213. doi: 10.1002/humu.23562. Epub 2018 Jun 28.

PMID:
29882371
3.

GARFIELD-NGS: Genomic vARiants FIltering by dEep Learning moDels in NGS.

Ravasio V, Ritelli M, Legati A, Giacopuzzi E.

Bioinformatics. 2018 Sep 1;34(17):3038-3040. doi: 10.1093/bioinformatics/bty303.

PMID:
29668842
4.

Risk Factors and Outcomes of Endocarditis Due to Non-HACEK Gram-Negative Bacilli: Data from the Prospective Multicenter Italian Endocarditis Study Cohort.

Falcone M, Tiseo G, Durante-Mangoni E, Ravasio V, Barbaro F, Ursi MP, Pasticci MB, Bassetti M, Grossi P, Venditti M, Rizzi M.

Antimicrob Agents Chemother. 2018 Mar 27;62(4). pii: e02208-17. doi: 10.1128/AAC.02208-17. Print 2018 Apr.

5.

Genomic and biochemical characterization of sialic acid acetylesterase (siae) in zebrafish.

Ravasio V, Damiati E, Zizioli D, Orizio F, Giacopuzzi E, Manzoni M, Bresciani R, Borsani G, Monti E.

Glycobiology. 2017 Oct 1;27(10):938-946. doi: 10.1093/glycob/cwx068.

PMID:
28922741
6.

Candida endocarditis: systematic literature review from 1997 to 2014 and analysis of 29 cases from the Italian Study of Endocarditis.

Giuliano S, Guastalegname M, Russo A, Falcone M, Ravasio V, Rizzi M, Bassetti M, Viale P, Pasticci MB, Durante-Mangoni E, Venditti M.

Expert Rev Anti Infect Ther. 2017 Sep;15(9):807-818. doi: 10.1080/14787210.2017.1372749. Epub 2017 Sep 14. Review.

PMID:
28903607
7.

A recognizable systemic connective tissue disorder with polyvalvular heart dystrophy and dysmorphism associated with TAB2 mutations.

Ritelli M, Morlino S, Giacopuzzi E, Bernardini L, Torres B, Santoro G, Ravasio V, Chiarelli N, D'Angelantonio D, Novelli A, Grammatico P, Colombi M, Castori M.

Clin Genet. 2018 Jan;93(1):126-133. doi: 10.1111/cge.13032. Epub 2017 Aug 21.

PMID:
28386937
8.

Current features of infective endocarditis in persons on hemodialysis: a prevalence study with case control design from the prospective multicenter SEI cohort.

Durante-Mangoni E, Pafundi PC, Ravasio V, Barbaro F, Bassetti M, Chinello P, Falcone M, Pasticci MB, Scotton PG, Stellini R, Tripodi MF, Utili R, Rizzi M.

Infection. 2016 Aug;44(4):467-74. doi: 10.1007/s15010-015-0870-y. Epub 2016 Jan 19.

PMID:
26780903
9.

Infective endocarditis in patients with hepatic diseases.

Seminari E, De Silvestri A, Ravasio V, Ludovisi S, Utili R, Petrosillo N, Castelli F, Bassetti M, Barbaro F, Grossi P, Barzaghi N, Rizzi M, Minoli L.

Eur J Clin Microbiol Infect Dis. 2016 Feb;35(2):279-84. doi: 10.1007/s10096-015-2541-4. Epub 2015 Dec 21.

PMID:
26690071
10.

In silico identification of new putative pathogenic variants in the NEU1 sialidase gene affecting enzyme function and subcellular localization.

Bonardi D, Ravasio V, Borsani G, d'Azzo A, Bresciani R, Monti E, Giacopuzzi E.

PLoS One. 2014 Aug 25;9(8):e104229. doi: 10.1371/journal.pone.0104229. eCollection 2014.

11.

OPERA: responses to peginterferon and ribavirin therapy in a subgroup of interferon-naïve patients with HIV/HCV genotype 2/3 co-infection in Italy.

Bruno R, Cariti G, Nasta P, Capetti A, Ravasio V, Galli M, Raise E, Palmieri G, Iannacone C, Puoti M.

Liver Int. 2015 Jan;35(1):120-9. doi: 10.1111/liv.12641. Epub 2014 Aug 11.

PMID:
25041136
12.

Predicting the occurrence of embolic events: an analysis of 1456 episodes of infective endocarditis from the Italian Study on Endocarditis (SEI).

Rizzi M, Ravasio V, Carobbio A, Mattucci I, Crapis M, Stellini R, Pasticci MB, Chinello P, Falcone M, Grossi P, Barbaro F, Pan A, Viale P, Durante-Mangoni E; Investigators of the Italian Study on Endocarditis.

BMC Infect Dis. 2014 Apr 29;14:230. doi: 10.1186/1471-2334-14-230.

13.

Drug reaction with eosinophilia and systemic symptoms associated with raltegravir use: case report and review of the literature.

Ripamonti D, Benatti SV, Di Filippo E, Ravasio V, Rizzi M.

AIDS. 2014 Apr 24;28(7):1077-9. doi: 10.1097/QAD.0000000000000204. Review. No abstract available.

PMID:
24685746
14.

OPERA: use of pegylated interferon plus ribavirin for treating HCV-HIV coinfection in interferon-naive patients.

Carosi G, Bruno R, Cariti G, Nasta P, Gulminetti R, Galli M, Angarano G, Verucchi G, Pontali E, Capetti A, Raise E, Ravasio V, Maida I, Iannacone C, Caputo A, Puoti M.

Antivir Ther. 2014;19(8):735-45. doi: 10.3851/IMP2757. Epub 2014 Feb 28.

PMID:
24583976
15.

In-hospital and 1-year mortality in patients undergoing early surgery for prosthetic valve endocarditis.

Lalani T, Chu VH, Park LP, Cecchi E, Corey GR, Durante-Mangoni E, Fowler VG Jr, Gordon D, Grossi P, Hannan M, Hoen B, Muñoz P, Rizk H, Kanj SS, Selton-Suty C, Sexton DJ, Spelman D, Ravasio V, Tripodi MF, Wang A; International Collaboration on Endocarditis–Prospective Cohort Study Investigators.

JAMA Intern Med. 2013 Sep 9;173(16):1495-504. doi: 10.1001/jamainternmed.2013.8203. Erratum in: JAMA Intern Med. 2013 Oct 28;173(19):1846.

PMID:
23857547
16.

Epidemiology, characteristics, and outcome of infective endocarditis in Italy: the Italian Study on Endocarditis.

Leone S, Ravasio V, Durante-Mangoni E, Crapis M, Carosi G, Scotton PG, Barzaghi N, Falcone M, Chinello P, Pasticci MB, Grossi P, Utili R, Viale P, Rizzi M, Suter F.

Infection. 2012 Oct;40(5):527-35. doi: 10.1007/s15010-012-0285-y. Epub 2012 Jun 19.

PMID:
22711599
17.

In vitro activity effects of twelve antibiotics alone and in association against twenty-seven Enterococcus faecalis strains isolated from Italian patients with infective endocarditis: high in vitro synergistic effect of the association ceftriaxone-fosfomycin.

Farina C, Russello G, Chinello P, Pasticci MB, Raglio A, Ravasio V, Rizzi M, Scarparo C, Vailati F, Suter F; Italian Infective Endocarditis Study Group (SEI).

Chemotherapy. 2011;57(5):426-33. doi: 10.1159/000330458. Epub 2011 Nov 26.

PMID:
22122863
18.

Changing Italian nosocomial-community trends and heteroresistance in Staphylococcus aureus from bacteremia and endocarditis.

Campanile F, Bongiorno D, Falcone M, Vailati F, Pasticci MB, Perez M, Raglio A, Rumpianesi F, Scuderi C, Suter F, Venditti M, Venturelli C, Ravasio V, Codeluppi M, Stefani S.

Eur J Clin Microbiol Infect Dis. 2012 May;31(5):739-45. doi: 10.1007/s10096-011-1367-y. Epub 2011 Aug 7.

19.

Bactericidal activity of oxacillin and glycopeptides against Staphylococcus aureus in patients with endocarditis: looking for a relationship between tolerance and outcome.

Pasticci MB, Moretti A, Stagni G, Ravasio V, Soavi L, Raglio A, Vailati F, Cardaccia A, Santucci A, Papili R, Sgrelli A, Pallotto C, Baldelli F.

Ann Clin Microbiol Antimicrob. 2011 Jun 9;10:26. doi: 10.1186/1476-0711-10-26.

20.

Causes of death and risk factors among HIV-infected persons in the HAART era: analysis of a large urban cohort.

Leone S, Gregis G, Quinzan G, Velenti D, Cologni G, Soavi L, Ravasio V, Ripamonti D, Suter F, Maggiolo F.

Infection. 2011 Feb;39(1):13-20. doi: 10.1007/s15010-010-0079-z. Epub 2011 Jan 19.

PMID:
21246246
21.

Mitochondrial changes during D-drug-containing once-daily therapy in HIV-positive treatment-naive patients.

Maggiolo F, Roat E, Pinti M, Nasi M, Gibellini L, De Biasi S, Airoldi M, Ravasio V, Mussini C, Suter F, Cossarizza A.

Antivir Ther. 2010;15(1):51-9. doi: 10.3851/IMP1483.

PMID:
20167991
22.

Candida infective endocarditis: report of 15 cases from a prospective multicenter study.

Falcone M, Barzaghi N, Carosi G, Grossi P, Minoli L, Ravasio V, Rizzi M, Suter F, Utili R, Viscoli C, Venditti M; Italian Study on Endocarditis.

Medicine (Baltimore). 2009 May;88(3):160-8. doi: 10.1097/MD.0b013e3181a693f8.

23.

Reduced valve replacement surgery and complication rate in Staphylococcus aureus endocarditis patients receiving acetyl-salicylic acid.

Eisen DP, Corey GR, McBryde ES, Fowler VG Jr, Miro JM, Cabell CH, Street AC, Paiva MG, Ionac A, Tan RS, Tribouilloy C, Pachirat O, Jones SB, Chipigina N, Naber C, Pan A, Ravasio V, Gattringer R, Chu VH, Bayer AS; ICE Investigators.

J Infect. 2009 May;58(5):332-8. doi: 10.1016/j.jinf.2009.03.006. Epub 2009 Mar 20.

PMID:
19342103
24.

CD4 cell-guided scheduled treatment interruptions in HIV-infected patients with sustained immunologic response to HAART.

Maggiolo F, Airoldi M, Callegaro A, Martinelli C, Dolara A, Bini T, Gregis G, Quinzan G, Ripamonti D, Ravasio V, Suter F.

AIDS. 2009 Apr 27;23(7):799-807. doi: 10.1097/QAD.0b013e328321b75e.

PMID:
19114869
25.

Effect of adherence to HAART on virologic outcome and on the selection of resistance-conferring mutations in NNRTI- or PI-treated patients.

Maggiolo F, Airoldi M, Kleinloog HD, Callegaro A, Ravasio V, Arici C, Bombana E, Suter F.

HIV Clin Trials. 2007 Sep-Oct;8(5):282-92.

PMID:
17956829
26.

Prediction of Virologic Outcome of Salvage Antiretroviral Treatment by Different Systems for Interpreting Genotypic HIV Drug Resistance.

Maggiolo F, Airoldi M, Callegaro A, Ripamonti D, Gregis G, Quinzan G, Bombana E, Ravasio V, Suter F.

J Int Assoc Physicians AIDS Care (Chic). 2007 Jun;6(2):87-93.

PMID:
17537998
27.

Resistance costs and future drug options of antiretroviral therapies: analysis of the role of NRTIs, NNRTIs, and PIs in a large clinical cohort.

Maggiolo F, Ripamonti D, Airoldi M, Callegaro A, Arici C, Ravasio V, Bombana E, Goglio A, Suter F.

HIV Clin Trials. 2007 Jan-Feb;8(1):9-18.

PMID:
17434844
28.
29.

Reasons for discontinuation of nevirapine-containing HAART: results from an unselected population of a large clinical cohort.

Maggiolo F, Arici C, Airoldi M, Ripamonti D, Quinzan G, Gregis G, Ravasio V, Bombana E, Suter F.

J Antimicrob Chemother. 2007 Mar;59(3):569-72. Epub 2007 Jan 25.

PMID:
17255141
30.

Long-term clinical benefit after highly active antiretroviral therapy in advanced HIV-1 infection, even in patients without immune reconstitution.

Arici C, Ripamonti D, Ravasio V, Maggiolo F, Rizzi M, Finazzi MG, Suter F.

Int J STD AIDS. 2001 Sep;12(9):573-81.

PMID:
11516366

Supplemental Content

Loading ...
Support Center